deucravacitinib
bms
['psoriasis', 'bms', 'scienceatbms']
this saturday at #eadvcongress, join us for a presentation on safety including covid-19 rates from our phase 3 trial in plaque #psoriasis.
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: